Literature DB >> 12955705

Acquired reactive perforating collagenosis in a nondiabetic hemodialysis patient: successful treatment with allopurinol.

Masayuki Iyoda1, Fumihiro Hayashi, Aki Kuroki, Takanori Shibata, Kozo Kitazawa, Tetsuzo Sugisaki, Osamu Sakai.   

Abstract

The authors present a case of acquired reactive perforating collagenosis developed in a nondiabetic hemodialysis patient, who was treated successfully with allopurinol. Treatment of acquired reactive perforating collagenosis is difficult and often ineffective. The patient had been unresponsive to conventional treatments, but the pruritus was controlled, and skin lesions subsequently resolved after the treatment with allopurinol. Possible mechanisms of allopurinol treatment for acquired reactive perforating collagenosis are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955705     DOI: 10.1016/s0272-6386(03)00796-0

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  2 in total

1.  A clinicopathologic study of thirty cases of acquired perforating dermatosis in Korea.

Authors:  Seo Wan Kim; Mi Sun Kim; June Hyunkyung Lee; Sook-Ja Son; Kui Young Park; Kapsok Li; Seong Jun Seo; Tae Young Han
Journal:  Ann Dermatol       Date:  2014-04-30       Impact factor: 1.444

2.  Allopurinol in the treatment of acquired reactive perforating collagenosis.

Authors:  Hemma Tilz; Jürgen Christian Becker; Franz Legat; Antonio Pedro Mendes Schettini; Martin Inzinger; Cesare Massone
Journal:  An Bras Dermatol       Date:  2013 Jan-Feb       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.